The Decision-making Value of Magnetic Resonance Cholangiopancreatography in Patients Suspicious for Pancreatobiliary Diseases.
- Author:
Yun Jung CHANG
1
;
Jae Seon KIM
;
Hyoung Seuk KIM
;
Myung Gyu KIM
;
Ji Yeon LEE
;
Yeon Seok SEO
;
Cheol Hyun KIM
;
Jin Yong KIM
;
Jong Eun YEON
;
Jong Jae PARK
;
Kwan Soo BYUN
;
Young Tae BAK
;
Chang Hong LEE
Author Information
1. Department of Internal Medicine, Hallym University College of Medicine, Seoul, Korea. kimjs@kumc.or.kr
- Publication Type:Original Article ; English Abstract
- Keywords:
Pancreatobiliary disease;
Magnetic resonance cholangiopancreatography
- MeSH:
Aged;
Biliary Tract Diseases/*diagnosis;
Cholangiopancreatography, Endoscopic Retrograde;
*Cholangiopancreatography, Magnetic Resonance;
Female;
Humans;
Male;
Middle Aged;
Pancreatic Diseases/*diagnosis
- From:The Korean Journal of Gastroenterology
2006;47(4):306-311
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND/AIMS: Endoscopic retrograde cholangiopancreatography (ERCP) is an operator-dependent procedure and has significant procedure-related morbidity and mortality. Magnetic resonance cholangiopancreatography (MRCP) is a safe noninvasive method for pancreatobiliary imaging. The aims of this study were to evaluate the potential impact of MRCP on performing ERCP and to evaluate the decision-making value of MRCP in patients suspicious for pancreatobiliary diseases. METHODS: Two hundreds twelve patients (M:F 108:104, mean age 59.3+/-13.7) who underwent MRCP due to clinical or sonographic suggesting pancreatobiliary disease were included. We divided patients into four groups according to their presumptive diagnosis: biliary stone (group 1), biliary tumor (group 2), gallstone pancreatitis (group 3) and other biliary diseases (group 4). RESULTS: Numbers of cases in group 1, 2, 3 and 4 were 145, 43, 17 and 7, respectively. In 144 cases (67.9%), ERCP was unnecessary and 76 cases (35.8%) required neither ERCP nor any other treatment. Thereafter, these cases were thought to be a patient group in whom the workload of performing ERCP could be reduced. CONCLUSIONS: MRCP can reduce the number and efforts doing ERCP and is helpful in decision-making for the treatment of pancreatobiliary disease. Therefore, MRCP could be the primary diagnostic tool before choosing ERCP.
